Nina Ramdas
About Nina Ramdas
Nina Ramdas is a Risk Management Strategy/Implementation Manager at Bristol-Myers Squibb with over 20 years of experience in drug safety and risk management.
Current Position at Bristol-Myers Squibb
Nina Ramdas is presently the Risk Management Strategy/Implementation Manager within the Global Risk Management and Worldwide Patient Safety division at Bristol-Myers Squibb in the United States. In this role, she focuses on overseeing and implementing risk management strategies to ensure patient safety on a global scale. She has held this position since 2018, following a transition from her previous role at Eli Lilly and Company.
Previous Role at Eli Lilly and Company
Before joining Bristol-Myers Squibb, Nina Ramdas worked as a Clinical Research Scientist (Safety Lead) in the Global Patient Safety Medical - Oncology division at Eli Lilly and Company. Between 2010 and 2017, she was based in Bridgewater, NJ, where she honed her expertise in oncology safety. This role provided her with extensive experience in managing patient safety for oncology products.
Career Progression at Imclone Systems Incorporated
Nina Ramdas worked at Imclone Systems Incorporated in various roles from 2001 to 2010. She started as a Drug Safety Specialist and progressed to Drug Safety Specialist II, Drug Safety Supervisor, Drug Safety Manager, and finally Senior Manager, Global Drug Safety. Her long tenure at Imclone Systems, located in Branchburg and Bridgewater, NJ, reinforced her skills in drug safety management and leadership.
Role at Novartis
In 2000, Nina Ramdas joined Novartis as a Clinical Safety Scientist in the Clinical Safety and Epidemiology department. During her seven-month stint in East Hanover, NJ, she gained valuable experience in clinical safety and epidemiology. This role laid the foundation for her subsequent positions in drug safety and risk management.
Educational Background
Nina Ramdas attended Volgograd State Medical University, where she achieved her Doctor of Medicine (MD) degree. She further completed an Internship in Internal Medicine at the same institution. These qualifications have been fundamental in her over 20-year career span in drug safety and risk management.